Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central GABAergic systems and depressive illness.

G Tunnicliff1, E Malatynska

  • 1Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 8600 University Boulevard, Evansville, Indiana 47712, USA. gtunnic@iupui.edu

Neurochemical Research
|April 30, 2003
PubMed
Summary

This study explores the role of GABAergic mechanisms in depression, suggesting they may be a key factor alongside traditional monoamine theories. Findings support GABA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex.

Neurochemistry international·2010
Same author

Bicuculline-insensitive GABA binding to catfish neuronal membranes.

Neurochemistry international·2010
Same author

Regulation of ?-aminobutyric acid synthesis in the vertebrate nervous system.

Neurochemistry international·2010
Same author

Action of analogues on ?-aminobutyric acid recognition sites in rat brain.

Neurochemistry international·2010
Same author

A relationship between synaptosomal GABA uptake and blood pressure in five inbred strains of mice.

Neurochemistry international·2010
Same author

Different levels of gamma-synuclein mRNA in the cerebral cortex of dominant, neutral and submissive rats selected in the competition test.

Genes, brain, and behavior·2005

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • Mood disorders, including depression, are prevalent but treatment is often ineffective.
  • Historically, monoamine function alterations were considered the primary cause of depression.
  • Emerging evidence suggests GABAergic mechanisms may also contribute to depression pathophysiology.

Purpose of the Study:

  • To investigate the potential role of GABAergic mechanisms in the development and progression of depression.
  • To synthesize direct and indirect evidence linking GABAergic function to mood disorders.

Main Methods:

  • Analysis of clinical data from depressed patients, including brain imaging, postmortem samples, cerebrospinal fluid (CSF), and serum.
  • In vivo and in vitro animal studies assessing the interaction between antidepressant drugs and the GABAergic system.

Related Experiment Videos

Main Results:

  • Direct clinical evidence indicates alterations in GABAergic systems in depressed individuals.
  • Indirect evidence from animal studies shows interactions between antidepressants and GABAergic pathways.
  • Data from both direct and indirect studies consistently suggest GABAergic involvement in depression.

Conclusions:

  • GABAergic mechanisms represent a significant, potentially underappreciated, factor in depression.
  • Further research into GABAergic pathways could lead to novel therapeutic strategies for mood disorders.
  • The findings challenge the sole reliance on monoamine-based theories and support a more complex understanding of depression.